Thrive Life

Thrive Earlier Detection is a healthcare company focused on incorporating early cancer detection into routine medical care. The company's flagship product, CancerSEEK, is a liquid biopsy test designed to detect multiple types of cancer at early stages when they are most treatable. Developed by researchers at Johns Hopkins University, the technology combines the analysis of DNA mutations and protein biomarkers. Thrive was acquired by Exact Sciences in 2021 to accelerate the development and commercialization of multi-cancer screening. The company's approach aims to transform oncology by identifying malignancies through a simple blood draw during regular checkups.